PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-158

  1. 3,010 Posts.
    lightbulb Created with Sketch. 1837
    Please don’t confuse approval for a limited special access trial as “FDA approval” for the drug in general. Yes it is very positive but saying it is already an FDA approved drug is not quite true. IMO.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.